Suchen Sie nach Informationen zu Novartis Corporate Officers? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.novartis.us/about-us/our-leadership
The Executive Committee of Novartis. Under the leadership of Chief Executive Officer Vas Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors. Novartis Board of Directors
https://www.novartis.com/about/executive-committee
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors. Download the Novartis organizational structure (PDF 0.2 MB) Chief Executive Officer.
https://www.novartis.us/about-us/our-leadership/us-country-leadership
Chief of Staff, Office of the President, Novartis Institutes for BioMedical Research (NIBR) linkedin; Read biography. Courtney Piron. Courtney Piron. Vice President and Head, US Public Affairs. ... Head, US Corporate Responsibility and …
https://www.northernsteelvic.com.au/n-corporate-office/novartis-corporate-officers.html
Chief Executive Officer Vasant (Vas) Narasimhan, M.D. Read Biography President, Novartis Institutes for BioMedical Research (NIBR) James (Jay) Bradner, M.D. Read Biography President, Innovative Medicines US Victor Bulto Read Biography Chief Legal Officer Karen L. Hale Read Biography Chief Financial Officer Harry Kirsch Read Biography
https://www.novartis.com/investors/company-overview/corporate-governance
Novartis is fully committed to good corporate governance. The Group’s principles and rules on corporate governance are laid down in the Articles of Incorporation, the Regulations of the Board and the Charters of the Board Committees. The Board’s Governance, Sustainability and Nomination Committee reviews these principles and rules regularly ...
https://www.novartis.com/contacts
United States. Tel: +1 862 778 21 00. Monday - Friday. 8:30 a.m. - 5:00 p.m. EST. For product-related inquiries and medical information about our products, please contact the Novartis office in your country. For Media. For Investors. Product-Related Issues. Locations.
https://www.novartis.com/us-en/about/contact-us
General Contact. 1-888-NOW-NOVA (1-888-669-6682) Monday - Friday, 8:30am - 5:00pm ET. In case of Medical Emergency, please contact your Physician immediately.
https://www.novartis.com/investors
Learn how Novartis uses science-based innovation to create value over the longer term for our company, our shareholders, ... and do our part as a responsible corporate citizen. Learn More. ESG Updates: July 20, 2022 (PDF …
https://www1.novartis.com/investors/company-overview/corporate-governance
Language & Country Selector for Desktop. Global | en . Choose Location
https://www.novartis.us/corporate-responsibility/business-conduct/compliance
Novartis’ Chief Compliance Officer (CCO) is charged with the responsibility for developing, operating, and monitoring the compliance program. The CCO reports directly to the President of Novartis, Head Pharma North America and has the authority to report to the Board of Directors.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Novartis Corporate Officers gefunden haben.
